Inside the Lab: How Advances in Treatment for NSCLC and Melanoma Impact the Laboratory

Inside the Lab: How Advances in Treatment for NSCLC and Melanoma Impact the Laboratory is organized by American Society for Clinical Pathology (ASCP).

Activity Overview:
During this podcast, pathology experts will discuss the impact that advances in immunotherapies for NSCLC and melanoma have in the laboratory. In addition, the podcast features an ASCP Patient Champion, who shares the patient’s perspective on the importance of a timely, accurate diagnosis.

Learning Objectives:
Upon completion of this activity, you will be able to:
• Describe how targeted therapies and immunotherapies have improved treatment for melanoma and lung cancer
• Discuss how pathologists and laboratory professionals might improve the journey for patients with cancer
• Describe how biomarker testing benefits both early-and advanced-stage cancer patients
• Discuss the obstacles laboratories face when providing biomarker testing services for their patients